Hospira supplier risk profile Q1 2026: 112 shipments, 3 suppliers, India-focused sourcing footprint.
Hospira received 112 shipments in Q1 2026 across 3 suppliers and 2 countries. India accounted for 49% of shipments (55 total), with Pfizer Healthcare India dominating at 52 shipments. The company's import activity centers on HS Chapter 39 (plastics and plastic articles), driven primarily by packaging-related imports. Secondary sourcing from Italy via Pfizer Service rounds out the footprint.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
Hospira recorded zero sanctions watchlist matches in Q1 2026. No suppliers in the direct supply network registered forced-labor exposure under UFLPA screening.
3 distinct tier-1 suppliers in Q1 2026
| PFIZER HEALTHCARE INDIA | India | 52 |
| PFIZER SERVICE | Italy | 7 |
| BPREX PHARMA PACKAGING INDIA LT | India | 3 |
Share of Q1 2026 inbound shipments by source country
10 tier-2 + 19 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.